Cargando…

Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France

BACKGROUND: Human Papillomavirus (HPV) infection is known to be associated with a number of conditions including cervical, vaginal, vulvar, penile, anal neoplasias and cancers, oropharynx cancers and genitals warts (GW). Two prophylactic vaccines are currently available: a bivalent vaccine designed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riethmuller, Didier, Jacquard, Anne-Carole, Lacau St Guily, Jean, Aubin, François, Carcopino, Xavier, Pradat, Pierre, Dahlab, André, Prétet, Jean-Luc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433025/ https://www.ncbi.nlm.nih.gov/pubmed/25934423 http://dx.doi.org/10.1186/s12889-015-1779-1

Ejemplares similares

Epidemiological and economic burden of potentially HPV-related cancers in France
por: Abramowitz, Laurent, et al.
Publicado: (2018)

Prevention and control of HPV and HPV-related cancers in France: the evolving landscape and the way forward – a meeting report
por: Waheed, Dur-e-Nayab, et al.
Publicado: (2023)

Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine
por: Petry, Karl-Ulrich, et al.
Publicado: (2018)

Human papillomavirus genotype distribution in tonsil cancers
por: St Guily, Jean Lacau, et al.
Publicado: (2011)

New HPV16 viral biomarkers to understand the progression of cervical lesions towards cancer
por: Prétet, Jean-Luc, et al.
Publicado: (2014)

Single-dose nonavalent HPV vaccine: Need of the hour
por: Pal, Manidip, et al.
Publicado: (2020)

Loss of chance associated with sub-optimal HPV vaccination coverage rate in France
por: Uhart, Mathieu, et al.
Publicado: (2017)

Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study
por: Lefevre, Marine, et al.
Publicado: (2017)

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe
por: Hartwig, Susanne, et al.
Publicado: (2017)

Effect of Infliximab on the UVB-Induced Apoptosis of Keratinocytes Infected by HPV38 E6/E7
por: Aubin, François, et al.
Publicado: (2013)

Development and interlaboratory agreement of real-time PCR for HPV16 quantification in liquid-based cervical samples
por: Guenat, David, et al.
Publicado: (2018)

Exosomes and Other Extracellular Vesicles in HPV Transmission and Carcinogenesis
por: Guenat, David, et al.
Publicado: (2017)

Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain
por: De La Fuente, Jesús, et al.
Publicado: (2019)

Sensitivity of Human Papillomavirus (HPV) Lineage and Sublineage Variant Pseudoviruses to Neutralization by Nonavalent Vaccine Antibodies
por: Godi, Anna, et al.
Publicado: (2019)

Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations
por: Bosco, Liana, et al.
Publicado: (2021)

HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort Study
por: Baumann, Antoine, et al.
Publicado: (2021)

Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database
por: Lacau St Guily, Jean, et al.
Publicado: (2010)

Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: A referral hospital-based study in Sicily
por: Capra, Giuseppina, et al.
Publicado: (2017)

Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain
por: Perez, S., et al.
Publicado: (2017)

Age-Related Changes in the Fraction of Cervical Intraepithelial Neoplasia Grade 3 Related to HPV Genotypes Included in the Nonavalent Vaccine
por: Giannella, Luca, et al.
Publicado: (2019)

The exon junction complex core factor eIF4A3 is a key regulator of HPV16 gene expression
por: Meznad, Koceila, et al.
Publicado: (2021)

Correction to: Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain
por: Perez, S., et al.
Publicado: (2018)

The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
por: Patel, Cyra, et al.
Publicado: (2018)

Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity
por: Sias, Catia, et al.
Publicado: (2020)

Apoptotic HPV Positive Cancer Cells Exhibit Transforming Properties
por: Gaiffe, Emilie, et al.
Publicado: (2012)

Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial
por: Debernardi, Alice, et al.
Publicado: (2022)

Validation of Novaprep(®) HQ+ liquid-based cytology medium for high-risk human papillomavirus detection by hc2
por: Guenat, David, et al.
Publicado: (2016)

Prevalence and risk factors of human papillomavirus infection types 16/18/45 in a cohort of French females aged 15–23 years
por: Baudu, Ariane, et al.
Publicado: (2014)

Effect of school-based HPV vaccine campaigns on inequalities in uptake in France: the PrevHPV trial
por: Dussault, J, et al.
Publicado: (2023)

5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression
por: Morel, Adrien, et al.
Publicado: (2017)

Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis
por: Choi, Horace C. W., et al.
Publicado: (2018)

Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later – an exploratory study
por: Gilca, Vladimir, et al.
Publicado: (2018)

Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck
por: Fouret, P, et al.
Publicado: (2002)

Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents
por: Huon, Jean-François, et al.
Publicado: (2020)

Comparative RNA sequencing reveals that HPV16 E6 abrogates the effect of E6*I on ROS metabolism
por: Paget-Bailly, Philippe, et al.
Publicado: (2019)

Evaluation and validation of HPV real-time PCR assay for the detection of HPV DNA in oral cytobrush and FFPE samples
por: Harlé, Alexandre, et al.
Publicado: (2018)

Co-occurrence of human papillomavirus (HPV) in newborns and their parents
por: Skoczyński, Mariusz, et al.
Publicado: (2019)

A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France
por: Bresse, Xavier, et al.
Publicado: (2013)

Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70
por: Chen, Zigui, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pt6mdthhsboisvvch2uk9tgg0n